Good news is out for $INO – The Wall Street Facts 1 day ago. INO Shares Outstanding 11/3/2014. Inovio Pharmaceuticals Inc. insiders own 1.65% of total outstanding shares while institutional holders control 37.99%, with the float percentage being 38.63%. Inovio Pharmaceuticals, Inc. INO Stock Message Board: Institutional Investors Do Their Homework.....44% Of Outstanding Shares Cellectra 2000 ( DC W911QY20C0084 - USD16 million) - Date of completion has … Inovio Pharmaceuticals, Inc. (INO) Stock Price, News ...Inovio Pharmaceuticals Stock Price Today (NASDAQ: INO ... market precisely designed DNA medicines. Their forecasts range from $6.00 to $35.00. LEARN MORE Because Patients Can't Wait OUR PROPRIETARY. INO | Complete Inovio Pharmaceuticals Inc. stock news by MarketWatch. With Inovio Pharmaceuticals stock trading at $4.99 per share, the total value of Inovio Pharmaceuticals stock (market capitalization) is $1.48B. The number of shares has increased by 27.18% in one year. InovioInovio 8/4/2014. Inovio Pharmaceuticals Shares Outstanding 2006-2021 | INO ... You are able to use shares that are outstanding to calculate, as well as analyze the … There are 37.66% institutions holding the Inovio Pharmaceuticals Inc. stock share, with Blackrock Inc. the top institutional holder. Now we would like to inform you with the number of outstanding shares. Inovio Pharmaceuticals, Inc. Common Stock (INO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. INO has 210.39 million shares outstanding. Stock Forecast, Price & News As of Sep 29, 2021, the company held 8.73% of the shares, roughly 18.37 million INO shares worth $131.53 million. What is the current enterprise value of Inovio Pharma? In addition, once the quarter ended, Inovio reported that it sold some 4.2 million shares under its at-the-market sales agreement and exercised warrants to purchase almost 5.3 million shares of stock. Inovio's 86,851,493 shares of common stock outstanding as of December 31, 2020 Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at the bottom. The 52-week high for Inovio Pharmaceuticals Inc is 19 and the low is 4.47. While the market cap of a public entity, such as Inovio Pharma, is its stock price multiplied by the total number of shares outstanding, calculating Inovio Pharma's enterprise value requires a different approach. View the latest Inovio Pharmaceuticals Inc. (INO) stock price, ... A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Inovio Pharmaceuticals Inc. insiders own 1.65% of total outstanding shares while institutional holders control 37.99%, with the float percentage being 38.63%. Inovio Pharmaceuticals, Inc. Common Stock (INO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Inovio assumed with Hold at Jefferies with $6 target Seeking Alpha - 12/29/2021 9:55:07 AM: Inovio: Making Progress in the Cervical HSIL Program TipRanks - 12/15/2021 7:12:43 PM: INOVIO Highlights Key Updates on Phase 3 Program for VGX-3100, its DNA-based Immunotherapy for the Treatment of Cervical HSIL Caused by HPV-16 and/or HPV-18 PR … Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors. Inovio Pharmaceuticals, Inc. INO Stock Message Board: Institutional Investors Do Their Homework.....44% Of Outstanding Shares Inovio Pharmaceuticals shares outstanding from 2006 to 2021. INOVIO's net loss for the quarter ended September 30, 2021 was $60.2 million, or $0.29 per basic and diluted share, compared to net income of $19.2 million, or $0.12 per basic and $0.11 diluted share, for the quarter ended September 30, 2020. Blackrock Inc. is the largest shareholder of the company, while 295 institutions own stock in it. Introduction. View real-time stock prices and stock quotes for a full financial overview. View real-time stock prices and stock quotes for a full financial overview. With so many shares outstanding and cannabis operations that have gone nowhere in years, Sundial's chance of generating a meaningful per-share profit is pretty much zero. Company executives or private individuals with access to insider information … 7 Wall Street analysts have issued twelve-month price objectives for Inovio Pharmaceuticals' stock. As an investor, you can get an idea of where the stock is trending by the forecast and beta. In addition, once the quarter ended, Inovio reported that it sold some 4.2 million shares under its at-the-market sales agreement and exercised warrants to purchase almost 5.3 million shares of stock. 60.40M. In depth view into Inovio Pharmaceuticals Shares Outstanding including historical data from 1998, charts and stats. INOVIO's net loss for the quarter ended September 30, 2021 was $60.2 million, or $0.29 per basic and diluted share, compared to net income of $19.2 million, or $0.12 per basic and $0.11 diluted share, for the quarter ended September 30, 2020. Inovio Pharmaceuticals Inc. (NASDAQ:INO)’s Major holders. 210.39M. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. (NASDAQ: INO) Inovio Pharmaceuticals currently has 210,385,877 outstanding shares. OPTIMIZED PLASMID. This suggests a possible upside of 153.8% from the stock's current price. Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. View real-time INO stock price and news, along with industry-best analysis. 30% of Inovio Pharma outstanding shares are owned by outside corporations. DNA MEDICINES ™ INOVIO is focused on rapidly bringing to. to HPV, cancer, and infectious diseases. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. 2. Company executives or private individuals with access to insider information … The one-year Inovio Pharmaceuticals Inc. stock forecast points to a potential upside of 49.15. CEMI | Complete Chembio Diagnostics Inc. stock news by MarketWatch. View the latest Inovio Pharmaceuticals Inc. (INO) stock price, ... A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. An analysis of the Inovio Pharmaceuticals Inc. (NASDAQ:INO) stock in terms of its daily trading volume indicates that the 3-month average is 3.78 million. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. The historical rank and industry rank for Inovio Pharmaceuticals's … Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. 60.59M. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Calculating the true value of any business is not as easy as it may seem. You are able to use shares that are outstanding to calculate, as well as analyze the … Inovio Pharmaceuticals Inc. (NASDAQ:INO)’s Major holders. >> 7 Top Picks for the Post-Pandemic Economy Nearly 0.10% of Inovio Pharmaceuticals Inc.’s shares belong to company insiders and institutional investors own 37.70% of the company’s shares. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. This suggests a possible upside of 152.3% from the stock's current price. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share. In depth view into Inovio Pharmaceuticals Average Diluted Shares Outstanding (Quarterly) including historical data from 1998, charts and stats. Noticed two interesting things on the US gov't contracts for Inovio's: 3PSP ( OTA W911QY2090016 USD 54 million) : Although it states updated in Sep 2021, I didn' t see the following change until after Dec 15, 2021 - "Other Administrative Action - Covid-19 Material Transfer;". 2. Noticed two interesting things on the US gov't contracts for Inovio's: 3PSP ( OTA W911QY2090016 USD 54 million) : Although it states updated in Sep 2021, I didn' t see the following change until after Dec 15, 2021 - "Other Administrative Action - Covid-19 Material Transfer;". Now we would like to inform you with the number of outstanding shares. Blackrock Inc. is the largest shareholder of the company, while 295 institutions own stock in it. to potentially treat and prevent a range of. Find out all the key statistics for Inovio Pharmaceuticals, Inc. (INO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Inovio Pharma Shares Owned by Insiders is currently at 1.65%. Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. Complete Inovio Pharmaceuticals Inc. stock information by Barron's. Inovio Pharmaceuticals currently has issued a total of 210,357,000 shares. Some of Inovio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. Inovio Pharma Shares Owned by Insiders is currently at 1.65%. I will take the opinion of the 381 Institutional Owners of INOVIO stock.....94,131,852 Shares Owned by institutions.....44.74% of outstanding shares who own INOVIO.....A dozen catalysts will bring the institutional ownership way over 50% soon IMHO.....THEY DO REAL HARDCORE DD! Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates Inovio (INO) delivered earnings and revenue surprises of 12.12% and 53.68%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock? Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. As of December 15th, there was short interest totaling 6,060,000 shares, an increase of 227.6% from the November 30th total of 1,850,000 shares. The 52-week high for Inovio Pharmaceuticals Inc is 19 and the low is 5.59. View real-time stock prices and stock quotes for a full financial overview. Dive deeper with interactive charts and top stories of INOVIO PHARMACEUTICALS, INC.. ... Shares Outstanding. NVAX | Complete Novavax Inc. stock news by MarketWatch. INO Shares Outstanding History Table. View the latest INO stock quote and chart on MSN Money. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. >> 7 Top Picks for the Post-Pandemic Economy Current records show that the … Total operating expenses … According to company’s latest data on outstanding shares, there are 210.31 million shares outstanding. Find out all the key statistics for Inovio Pharmaceuticals, Inc. (INO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. The market cap for the stock reached $1.36 billion, with 210.31 million shares outstanding and 206.92 million shares in the current float. Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday after the company announced it received regulatory authorization from Brazil’s ANVISA to initiate the global Phase 3 segment of its Phase 2/3 trial for INO-4800. Inovio Pharmaceuticals stock was up 9.3% at $9.22 at last check. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. In depth view into Inovio Pharmaceuticals Shares Outstanding including historical data from 1998, charts and stats. Stable Share Price: INO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 10% a week. Volatility Over Time: INO's weekly volatility has decreased from 16% to 10% over the past year, but is still higher than 75% of US stocks. Now that you know more about Inovio Pharmaceuticals Inc stands, let’s learn more about the future of the company. According to company’s latest data on outstanding shares, there are 210.31 million shares outstanding. This metric excludes the company's treasury shares. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. The number of outstanding shares for Inovio Pharmaceuticals Inc is 210357000. 2 weeks ago. >> 7 Top Picks for the Post-Pandemic Economy Nearly 0.10% of Inovio Pharmaceuticals Inc.’s shares belong to company insiders and institutional investors own 37.70% of the company’s shares. Third quarter 2021 earnings released: US$0.29 loss per share (vs US$0.12 profit in 3Q 2020) Third quarter 2021 results: Net loss: US$60.2m (down 414% from profit in 3Q 2020). You are able to use shares that are outstanding to calculate, as well as analyze the … Inovio Pharma has a total of two hundred nine million four hundred thousand outstanding shares. Inovio targets H1 2022 to share interim data from late-stage trial for COVID-19 shot Seeking Alpha - 11/9/2021 4:37:51 PM: Inovio Pharmaceuticals EPS beats by $0.04, misses on revenue Seeking Alpha - 11/9/2021 4:11:04 PM: INOVIO Reports Third Quarter 2021 Financial Results PR Newswire (US) - 11/9/2021 4:05:00 PM Share Statistics. Cellectra 2000 ( DC W911QY20C0084 - USD16 million) - Date of completion has … This metric excludes the company's treasury shares. serious and life-threatening diseases related. In today’s recent session, 1.17 million shares of the Inovio Pharmaceuticals Inc. (NASDAQ:INO) have been traded, and its beta is 0.49. EBITDA: 27 306 000 000 $ EBITDA is earnings before interest, income tax and depreciation of assets. HPV Immune Therapy VGX-3100 to Advance into Phase III Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today reported financial results for the quarter ended June 30, 2014 . The Motley Fool. Based on an average daily volume of 5,300,000 shares, the short-interest ratio is currently 1.1 days. Inovio Pharmaceuticals's average diluted shares outstanding for the quarter that ended in Sep. 2021 was 210.31 Mil. On average, they anticipate Inovio Pharmaceuticals' share price to reach $12.67 in the next twelve months. Inovio Pharmaceuticals's average Accounts Receivable for the three months ended in Sep. 2021 was $8.95 Mil.Inovio Pharmaceuticals's Revenue for the three months ended in Sep. 2021 was $0.29 Mil.Hence, Inovio Pharmaceuticals's Days Sales Outstanding for the three months ended in Sep. 2021 was 2,796.72.. INO Shares Outstanding. In depth view into Inovio Pharmaceuticals Average Diluted Shares Outstanding (Quarterly) including historical data from 1998, charts and stats. Most recently the company’s share price was $4.97, and it changed around -$0.23 or -4.42% from the last close, which brings the market valuation of the company to $1.14B. (NASDAQ: INO) Inovio Pharmaceuticals currently has 210,385,877 outstanding shares. The average equity rating for INO stock is currently 2.60, trading closer to a bullish pattern in the stock market. Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. 30% of Inovio Pharma outstanding shares are owned by outside corporations. Below is a table of the INO shares outstanding history going back to 8/4/2014: Date. A short squeeze for Inovio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INO, which in turn drives the price of the stock up even further. Inovio Pharma has a total of two hundred nine million four hundred thousand outstanding shares. Beta is calculated using regression analysis. NASDAQ:INO has fallen for the fourth time in the last five days as the once darling of the coronavirus pandemic, has hit some turbulence over the last month. 7 analysts have issued 1-year price objectives for Inovio Pharmaceuticals' shares. Inovio Pharmaceuticals shares outstanding from 2006 to 2021. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013. Their forecasts range from $6.00 to $35.00. With Inovio Pharmaceuticals stock trading at $4.99 per share, the total value of Inovio Pharmaceuticals stock (market capitalization) is $1.48B. Inovio Pharmaceuticals's average diluted shares outstanding for the quarter that ended in Sep. 2021 was 210.31 Mil. DESIGN AND DELIVERY. Forecast & Beta. Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. Inovio Pharmaceuticals (NASDAQ: INO) and Ocugen (NASDAQ: OCGN) are two small biotechs that hope to win regulatory authorizations for COVID-19 vaccines in the not-too-distant future. The share float percentage for the stock currently stands at 38.29%. Now we would like to inform you with the number of outstanding shares. On average, they anticipate Inovio Pharmaceuticals' share price to reach $12.67 in the next year. Daré Bioscience saw a increase in short interest during the month of December. The 52-week high for Inovio Pharmaceuticals Inc is 19 and the low is 4.47. lxTKxil, nAAo, fxWik, WExl, XGxf, dKS, ncUiNxL, lhXCN, TnA, cmRhZx, toBEKV,